Rotenone induced neurotoxicity in rat brain areas: A histopathological study

Neuroscience Letters

Volumn 501, Issue 3, 2011, Pages 123-127

  Swarnkar, Supriya ^a   Singh, Sarika ^a   Sharma, Sharad ^a   Mathur, Ramesh ^b   Patro, Ishan K ^b   Nath, Chandishwar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b JIWAJI UNIVERSITY   (India)

Author keywords

Histopathology; Neuromuscular coordination; Neurotoxicity; Oxidative stress; Rotenone

Indexed keywords

EOSIN; GLUTATHIONE; HEMATOXYLIN; ROTENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; CORPUS STRIATUM; HISTOPATHOLOGY; MALE; MORPHOLOGY; MOTOR COORDINATION; NERVE CELL; NERVE CELL DEGENERATION; NEUROMUSCULAR SYSTEM; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STAINING; SUBSTANTIA NIGRA;

ANIMALS; BRAIN; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; INSECTICIDES; MALE; NERVE DEGENERATION; NEURONS; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; SUBSTANTIA NIGRA;

EID: 79961210983     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.03.036     Document Type: Article

References (20)

1. Alam M., Schmidt W.J. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav. Brain Res. 2002, 136:317-324.
2. Betarbet R., Sherer T.B., MacKenzie G., Osuna M.G., Pavanov V.A., Greenamyre T.J. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3:1301-1306.
3. Caban-Holt A., Mattingly M., Cooper G., Schmitt F.A. Neurodegenerative memory disorders, a potential role of environmental toxins. Neurol. Clin. 2005, 23:485-521.
4. Colado M.I., O'Shea E., Granados R., Misra A., Murray T.K., Green A.R. A study of the neurotoxic effect of MDMA (" ectasy" ) on 5-HT neurons in the brains of mothers and neonates following administration of the drug during pregnancy. Brit. J. Pharmacol. 1997, 121:827-833.
5. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. The disposition of [3H] norepinephrine [3H] dopamine and [3H] DOPA in various regions of the brain. J. Neurochem. 1966, 13:655-670.
6. Gupta Y.K., Sharma M. Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats. Eur. Neuropsychol. Pharmacol. 2003, 13:241-247.
7. Hemat R.A.S. Orthomolecularism: Principles and Practice 2004, Author House, Nutrients, p. 405. first ed.
8. Hirsch E.C., Graybiel A.M., Agid Y. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988, 334:345-348.
9. Kastner A., Hirsch E.C., Lejeune O., Javoy-Agid F., Rascol O., Agid Y. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?. J. Neurochem. 1992, 59:1080-1089.
10. Li Y., Powers C., Jiang N., Chopp M. Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat. J. Neurological. Sci. 1998, 156:119-132.
11. Lowry O.H., Rosebrough N.J., Farr A.I., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
12. Ludvig N., Sheffield L.G., Tang H.M., Baptiste S.L., Devinsky O., Kuzniecky R.I. Histological evidence for drug diffusion across the cerebral meninges into the underlying neocortex in rats. Brain Res. 2008, 1188:228-232.
13. Semper Marey, Gelman M., Levi Strauss M. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 1995, 15:5912-5918.
14. Paxinos G., Watson C. The Rat Brain in Sterotaxic Coordinates 1988, Academic Press, New York, pp. 1-120.
15. Rice-Evans C., Burdon R. Free radical-lipid interactions and their pathological consequences. Prog. Lipid Res. 1993, 32:71-110.
16. Rozas G., Labandeira-Garcói{dotless}a J.L. Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Brain Res. 1997, 749:188-199.
17. Saravanan K.S., Sindhu K.M., Mohanakumar K.P. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease. Brain Res. 2005, 1049:147-155.
18. Swarnkar S., Tyagi E., Agrawal R., Singh M.P., Nath C. A comparative study on oxidative stress induced by LPS and rotenone in homogenates of rat brain areas. Environ. Toxicol. Pharmacol. 2009, 27:219-224.
19. Swarnkar S., Singh S., Mathur R., Patro I.K., Nath C. A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats. Toxicology 2010, 272:17-22.
20. Uversky V.N. Neurotoxicant induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res. 2004, 318:225-241.